ABSTRACT
Background Associations between attention-deficit/hyperactivity disorder (ADHD) and brain morphology have been reported, although with several inconsistencies. These may partly stem from confounding bias, which could distort associations and limit generalizability. We examined how associations between brain morphology and ADHD symptoms change with adjustments for potential confounders typically overlooked in the literature (aim 1), and for IQ, which is typically corrected for but plays an unclear role (aim 2).
Methods Participants were 10-year-old children from the Adolescent Brain Cognitive Development (N=7,961) and Generation R (N=2,531) studies. Cortical area and volume were measured with MRI and ADHD symptoms with the Child Behavior Checklist. Surface-based cross-sectional analyses were run.
Results ADHD symptoms related to widespread cortical regions when solely adjusting for demographic factors. Additional adjustments for socioeconomic and maternal behavioral confounders (aim 1) generally attenuated associations, as cluster sizes halved and effect sizes substantially reduced. Cluster sizes were further reduced when including IQ (aim 2), however, we argue that adjustments could have introduced bias (e.g., by conditioning on a collider).
Conclusions Careful confounder selection and control can help identify more robust and specific regions of associations for ADHD symptoms, across two cohorts. We provided guidance to minimizing confounding bias in psychiatric neuroimaging.
Funding Authors are supported by an NWO-VICI grant (NWO-ZonMW: 016.VICI.170.200 to HT) for HT, LDA, SL, and the Sophia Foundation S18-20, and Erasmus University and Erasmus MC Fellowship for RLM.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123, U24DA041147. All supporters are mentioned at https://abcdstudy.org/federal-partners.html. Participating sites and study investigators are shown at https://abcdstudy.org/consortium_members/. While ABCD investigators designed, implemented the study, and/or provided data, they did not participate in this manuscript. This work reflects the authors' views, and may not reflect those of the NIH or ABCD investigators. The Generation R Study is supported by Erasmus MC, Erasmus University Rotterdam, the Rotterdam Homecare Foundation, the Municipal Health Service Rotterdam area, the Stichting Trombosedienst & Artsenlaboratorium Rijnmond, the Netherlands Organization for Health Research and Development (ZonMw), and the Ministry of Health, Welfare and Sport. Neuroimaging data acquisition was funded by the European Community's 7th Framework Program (FP7/2008-2013, 212652, Nutrimenthe). Netherlands Organization for Scientific Research (Exacte Wetenschappen) and SURFsara (Cartesius Compute Cluster, www.surfsara.nl) supported the Supercomputing resources. Authors are supported by an NWO-VICI grant (NWO-ZonMW: 016.VICI.170.200 to HT) for HT, LDA, SL, and the Sophia Foundation S18-20, and Erasmus University and Erasmus MC Fellowship for RLM.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research protocols for the ABCD study were approved by the institutional review board of the University of California, San Diego, and the institutional review boards of the 21 data collection sites, while the design of the Generation R study was approved by the Medical Ethics Committee of the Erasmus MC.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All datasets for this article are not automatically publicly available due to legal and informed consent restrictions. Reasonable requests to access the datasets should be directed to the Director of the Generation R Study, Vincent Jaddoe (generationr{at}erasmusmc.nl), in accordance with the local, national, and European Union regulations. Data for The ABCD Study is already open and available in the NIMH Data Archive (NDA) (https://nda.nih.gov/) to eligible researchers within NIH-verified institutions. Data can be accessed following a data request to the NIH data access committee (https://nda.nih.gov/), which should include information on the planned topic of study. The request is valid for one year. Data use should be in line with the NDA Data Use Certification. The code used for this study is publicly available at https://github.com/LorenzaDA/ADHD_brainmorphology_confounding
https://github.com/LorenzaDA/ADHD_brainmorphology_confounding
